BIG PHARMA UP TO NO GOOD ONCE AGAIN..................selling
drugs made of coconut oil at killer prices.
Alzheimer’s afflicts 5.2
million people in the US and is the 7th leading cause of death.
The cost of treating it is estimated at $148
billion.
Mary Newport, medical
director of the neonatal intensive care unit at Spring Hill
Regional Hospital in Florida, her husband Steve, was diagnosed with
Alzheimer’s Disease.
They started him on
Alzheimer’s drugs—Aricept, Namenda, Exelon—but his disease worsened
steadily.
She discovered that with
Alzheimer’s disease, certain brain cells may have difficulty
utilizing glucose (made from the carbohydrates we eat), the brain’s
principal source of energy. Without fuel, these precious neurons
may begin to die. There is an alternative energy source for brain
cells—fats known as ketones.
Another way to produce
ketones is by consuming oils that have medium-chain triglycerides.
When MCT oil is digested, the liver converts it into
ketones.
Dr. Newport learned that
the ingredient in the new drug trial which was showing so much
promise was simply MCT oil derived from coconut oil or palm kernel
oil, and that a dose of 20 grams (about 20 ml or 4 teaspoons) was
used to produce these results.
Mr. Newport, not being
able to get into the drug trial, started taking the coconut oil
twice a day. At this point, he could barely remember how to draw a
clock.
Over the next year, the
dementia reversed itself: his reading comprehension has improved
dramatically, and his short-term memory is improving—he often
brings up events that happened days to weeks earlier and relays
telephone conversations with accurate detail. A recent MRI shows
that the brain atrophy has been completely
halted.